Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Isabel Newton

Vascular & Interventional Radiology San Diego, CA Medical Doctor

NPI 1306068697 CMS profile 240530

200 W Arbor Dr, San Diego, CA 92103

Open in the dashboard

General payments

$193,431

323 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Isabel Newton of San Diego, CA is reported in the CMS Open Payments database as having received $193,431 across 323 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $51,698 46
2024 General $38,888 64
2023 General $31,795 43
2022 General $24,130 60
2021 General $25,580 43
2020 General $18,218 21
2019 General $3,123 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Isabel Newton
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Isabel Newton were reported at $51,698. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Isabel Newton Vascular & Interventional Radiology median Middle half National median
2019 $3,123 $422 $125–$1,555 $163
2020 $18,218 $200 $68–$652 $114
2021 $25,580 $280 $99–$866 $132
2022 $24,130 $433 $137–$1,497 $149
2023 $31,795 $506 $152–$2,019 $160
2024 $38,888 $556 $175–$1,930 $164
2025 $51,698 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $158,911 141 payments
  2. Varian Medical Systems, Inc. $9,807 4 payments
  3. AstraZeneca Pharmaceuticals LP $6,934 13 payments
  4. Penumbra, Inc. $4,989 17 payments
  5. Guerbet LLC $3,028 6 payments
  6. Cook Medical LLC $2,143 44 payments
  7. AstraZeneca UK Limited $1,343 1 payment
  8. Biocompatibles, Inc. $808 5 payments
  9. Viz.Ai, Inc. $777 5 payments
  10. Terumo Medical Corporation $536 11 payments
  11. Other $4,154 76 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $138,000 45 payments
  2. Food and Beverage $18,001 228 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,175 8 payments
  4. Travel and Lodging $12,256 41 payments
  5. Honoraria $9,000 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $60,490 30 payments
  2. General - Embolics $44,050 7 payments
  3. GENERAL PAIN MANAGEMENT $10,950 8 payments
  4. General Therapies $9,500 3 payments
  5. General - Therapies Therapies $8,000 6 payments
  6. Indigo System $4,714 14 payments
  7. General - Therapies General - Therapies_PI $3,658 15 payments
  8. IMFINZI $3,532 4 payments
  9. Lipiodol $3,028 6 payments
  10. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $1,064 2 payments
  11. Other $12,517 200 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

323 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record